Related references
Note: Only part of the references are listed.LncRNA UCA1 promotes renal cell carcinoma proliferation through epigenetically repressing p21 expression and negatively regulating miR-495
Yun Lu et al.
TUMOR BIOLOGY (2017)
Long Non Coding RNA-UCA1 Contributes to Cardiomyocyte Apoptosis by Suppression of p27 Expression
Youbin Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
The Cytoprotective Effect of Hyperoside against Oxidative Stress Is Mediated by the Nrf2-ARE Signaling Pathway through GSK-3β Inactivation
Hai-Yan Xing et al.
PLOS ONE (2015)
Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells
F. Wang et al.
NEOPLASMA (2015)
Activation of Nrf2-ARE signal pathway protects the brain from damage induced by epileptic seizure
Wei Wang et al.
BRAIN RESEARCH (2014)
Long-Term Effects of Peripubertal Binge EtOH Exposure on Hippocampal microRNA Expression in the Rat
Sarah A. Prins et al.
PLOS ONE (2014)
The emerging role of the Nrf2-Keap1 signaling pathway in cancer
Melba C. Jaramillo et al.
GENES & DEVELOPMENT (2013)
Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis
Andrea Pauli et al.
GENOME RESEARCH (2012)
Safety and prognosis of limited surgery for octogenarians with non-small-cell lung cancer
Akira Okada et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2012)
The cytoprotective role of the Keap1-Nrf2 pathway
Liam Baird et al.
ARCHIVES OF TOXICOLOGY (2011)
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Leonardo Salmena et al.
CELL (2011)
Negative Correlation between Expression Level and Evolutionary Rate of Long Intergenic Noncoding RNAs
David Managadze et al.
GENOME BIOLOGY AND EVOLUTION (2011)
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Alex Chang
LUNG CANCER (2011)
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Tao Jiang et al.
CANCER RESEARCH (2010)
Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
Ping Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Evolution and Functions of Long Noncoding RNAs
Chris P. Ponting et al.
CELL (2009)
Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells
Hanane Akhdar et al.
EUROPEAN JOURNAL OF CANCER (2009)
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
Anju Singh et al.
CANCER RESEARCH (2008)
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Xiao-Jun Wang et al.
CARCINOGENESIS (2008)
Specific expression of long noncoding RNAs in the mouse brain
Tim R. Mercer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
RNA maps reveal new RNA classes and a possible function for pervasive transcription
Philipp Kapranov et al.
SCIENCE (2007)
Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents
J Zhao et al.
NEUROSCIENCE LETTERS (2006)
Oxidative and electophilic stresses activate Nrf2 through inhibition of ubiquitination activity if Keap1
A Kobayashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prognosis of non-small cell lung cancer patients with positive pleural lavage cytology after a thoracotomy: results of the survey conducted by the Japan Clinical Oncology Group
Y Ichinose et al.
LUNG CANCER (2001)
Share Paper
